EnvisionIt Deep AI

EnvisionIt Deep AI is a South African health-tech startup that uses artificial intelligence (AI) to bridge the gap in diagnostic imaging. Founded in 2019 by Dr. Jaishree Naidoo, Andrei Migatchev, and Terence Naidu, the company develops innovative medical solutions that harness AI to transform how healthcare professionals diagnose and treat patients.

One of EnvisionIt Deep AI's key offerings is RADIFY AI, an AI-powered platform that enhances the speed, accuracy, quality, and affordability of medical imaging diagnosis. This technology plays a crucial role in the early detection and treatment of various diseases, including tuberculosis, coronavirus pneumonia, and breast cancer. In 2022, the startup screened and triaged 64,351 patients, demonstrating its capability to address the massive demand for healthcare services in Africa.

EnvisionIt Deep AI's products, like RADIFY AI, have received regulatory approval from the South African Health Products Regulatory Association, and the company is actively seeking clearance from the US Food and Drug Administration (FDA) and the European Medical Agency to expand its reach globally. The startup's solutions are designed to be deployed in both urban and rural settings, ensuring accessibility even in areas with limited infrastructure and broadband connectivity.

In January 2024, EnvisionIt Deep AI achieved a significant milestone by becoming the first African-founded company to receive FDA 510(k) clearance for its RADIFY AI device. This clearance allows RADIFY AI to triage pneumothorax and pleural effusion cases, addressing critical challenges in emergency rooms and intensive care units.